Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126002562 | 12600256 | 2 | F | 20151208 | 20160727 | 20160727 | PER | US-MYLANLABS-2015M1039595 | MYLAN | 0.00 | M | Y | 80.73000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126002562 | 12600256 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | UNK UNK, QD | U | 91226 | TABLET | QD | ||||||||
| 126002562 | 12600256 | 2 | SS | ATORVASTATIN | ATORVASTATIN | 1 | UNK UNK, QD | U | 91226 | TABLET | QD | ||||||||
| 126002562 | 12600256 | 3 | SS | ATORVASTATIN | ATORVASTATIN | 1 | UNK | U | 91226 | ||||||||||
| 126002562 | 12600256 | 4 | SS | ATORVASTATIN | ATORVASTATIN | 1 | U | 91226 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126002562 | 12600256 | 3 | Cardiac disorder |
| 126002562 | 12600256 | 4 | Blood cholesterol |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126002562 | 12600256 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |